SCHEMBL2963909

SCHEMBL2963909

O=C(O)CNCC(=O)O.O=C(O)CNCC(=O)OCCOCCO

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CA1 P00915 6/20 0.46
CA2 P00918 6/20 0.46
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
EPHX2 P34913 1/20 0.38
TSHR P16473 3/20 0.37
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 2/20 0.31
TP53 P04637 2/20 0.31
HIF1A Q16665 2/20 0.31
HSD17B10 Q99714 2/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31
THRB P10828 1/20 0.31
HTT P42858 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL892182 0.88 CA1 (0.46) CA1CA2TSHR
SCHEMBL11699076 0.86 CA1 (0.45) CA1CA2TSHR
Water SCHEMBL11884548 0.85 CA1 (0.44) CA1CA2TSHR
SCHEMBL29389722 0.81 CA1 (0.44) CA1CA2MEN1KMT2ATSHR
SCHEMBL8290813 0.80 MEN1 (0.48) MEN1KMT2AEPHX2TSHRMAPK1
SCHEMBL8295171 0.80 MEN1 (0.48) MEN1KMT2AEPHX2TSHRMAPK1
SCHEMBL10778073 0.80 TSHR (0.41) CA1CA2MEN1KMT2ATSHR
Trolamine SCHEMBL11786638 0.79 CA1 (0.40) CA1CA2MAPT
SCHEMBL21876953 0.79 MEN1 (0.46) MEN1KMT2AEPHX2TSHRMAPK1
SCHEMBL20913712 0.79 MEN1 (0.46) MEN1KMT2AEPHX2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5474906-A Using mixture of glutamyl-3-carboxy-4-nitroanilide and a transition metal salt stabilizer EIKEN KAGAKU KABUSHIKI KAISHA (JP) 1995-12-12 US claimed
EP-0617131-A1 Reagent for determining gamma-glutamyl transpeptidase EIKEN KAGAKU KABUSHIKI KAISHA (JP) 1994-09-28 EP claimed
US-20260089904-A1 CONDUCTIVE FILM AND ELECTROMAGNETIC WAVE SHIELDING MATERIAL USING SAME PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD. (JP) 2026-03-26 US disclosed
US-12565599-B2 Slurry, polishing method, and method for manufacturing semiconductor component RESONAC CORPORATION (JP) 2026-03-03 US disclosed
US-12522748-B2 Slurry, polishing method, and method for producing semiconductor component RESONAC CORPORATION (JP) 2026-01-13 US disclosed
WO-2024247973-A1 CONDUCTIVE FILM AND ELECTROMAGNETIC WAVE SHIELDING MATERIAL USING SAME パナソニックIPマネジメント株式会社 2024-12-05 WO disclosed
US-20230392043-A1 SLURRY, POLISHING METHOD, AND METHOD FOR MANUFACTURING SEMICONDUCTOR COMPONENT RESONAC CORPORATION (JP) 2023-12-07 US disclosed
US-20230357600-A1 SLURRY, POLISHING METHOD, AND METHOD FOR PRODUCING SEMICONDUCTOR COMPONENT RESONAC CORPORATION (JP) 2023-11-09 US disclosed
EP-3434253-B1 DENTAL ALGINATE IMPRESSION MATERIAL G C DENTAL IND CORP (JP) 2022-02-02 EP disclosed
US-10744071-B2 Dental alginate impression material GC CORPORATION (JP) 2020-08-18 US disclosed
US-20190076336-A1 DENTAL ALGINATE IMPRESSION MATERIAL GC CORPORATION (JP) 2019-03-14 US disclosed
EP-0607064-B1 Assay method and reagent for magnesium in human body fluids ORIENTAL YEAST CO LTD (JP) 2000-04-05 EP disclosed
US-5900899-A IMPROVED COLOR REPRODUCTION OF SHADES AND UNEVENNESS IN PRINTING; RUB RESISTANCE, REDUCED PRINT BLEEDING, EXCELLENT IMAGE QUALITY AND WATERFASTNESS FUJI XEROX CO., LTD. (JP) 1999-05-04 US disclosed
EP-0617131-B1 Reagent for determining gamma-glutamyl transpeptidase EIKEN CHEMICAL (JP) 1998-11-04 EP disclosed
US-5474906-A Using mixture of glutamyl-3-carboxy-4-nitroanilide and a transition metal salt stabilizer EIKEN KAGAKU KABUSHIKI KAISHA (JP) 1995-12-12 US disclosed
EP-0617131-A1 Reagent for determining gamma-glutamyl transpeptidase EIKEN KAGAKU KABUSHIKI KAISHA (JP) 1994-09-28 EP disclosed
EP-0607064-A1 Assay method and reagent for magnesium in human body fluids ORIENTAL YEAST CO., LTD. (JP) 1994-07-20 EP disclosed
EP-0240914-B1 PEPTIDE DERIVATIVES AND ACTIVITY MEASURING METHOD OF PHYSIOLOGICALLY ACTIVE SUBSTANCES USING THE SAME AS SUBSTRATES WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1992-08-19 EP disclosed
US-5120644-A Reacting enzyme with substrate containing fluorescent substituent WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1992-06-09 US disclosed
EP-0240914-A2 Peptide derivatives and activity measuring method of physiologically active substances using the same as substrates WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 1987-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12565599-B2 Slurry, polishing method, and method for manufacturing semiconductor component STIP1, SGK1, SGK3 CA1 904/4885CA2 2855/4885MEN1 1436/4885
US-20260089904-A1 CONDUCTIVE FILM AND ELECTROMAGNETIC WAVE SHIELDING MATERIAL USING SAME GJA1, GJB2, POT1 CA1 2007/4885CA2 3260/4885MEN1 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.